The TRADE

JANUARY 22, 2025

I spent the first 20 years of my career at the global bulge bracket banks, first in investment banking and then on the institutional equity desks, in a cross-asset and special situations role. I started my career at Bear Stearns in 2001, then migrated to Credit Suisse in 2008. There’s been a reopening in capital markets.

Funds 59

Funds Capital Capital Market S&P 59

InvestmentBank.com

OCTOBER 24, 2019

For the better part of the last decade, physician practices have seen a wave of consolidation by hospitals and private equity with 2018 being no exception [1]. In fact, acquisitions by hospitals and private equity in provider services broke records last year according to Bain & Co’s 2019 global healthcare report.

Hospitality 40

Hospitality Private Equity Equities Acquisitions 40

Software Equity Group

MARCH 13, 2023

The public markets may have taken a beating, but behind the gloom-and-doom headlines, there was still plenty of good news for private SaaS companies in 2022. On the surface, things looked rough: the Dow Jones, S&P 500, and the NASDAQ all finished the year with significant losses, with tech stocks hit particularly hard.

M&A 52

M&A Private Equity Equities S&P 52

Peak Frameworks

OCTOBER 17, 2023

Check out our , Private Equity Course and , Investment Banking Course , which help thousands of candidates land top jobs every year 3. Case in point, the collapse of Lehman Brothers in 2008 sent shockwaves through the commercial paper market. However, this doesn't mean they are risk-free, as the events of 2008 illustrated.

Finance 52

Finance Finance Debt Funds 52

Peak Frameworks

AUGUST 15, 2023

The Seven Indicators Stock Price Momentum : The S&P 500 versus its 125-day moving average. For example, during the 2008 financial crisis , the Fear and Greed Index tanked to extreme fear levels. The index uses seven market indicators to calculate a value ranging from 0 (Extreme Fear) to 100 (Extreme Greed).

Investors 52

Investors Stock Risk Management Investment 52

Cooley M&A

JANUARY 20, 2022

While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. on transactions over 2019’s mega?mergers. General trends in life sciences M&A.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40